Identification of high-confidence mitochondrial DNA mutations for Tapestri analysis.
Blood and bone marrow counts of immunosuppression tapering (IST) cohort from routine clinical measurements.
Differential phenotypes of physiologic (donor-) and malignant hematopoietic (recipient-derived) cells.
Mitochondrial and somatic nuclear DNA mutations identified in CLL using single cell DNA sequencing.
Longitudinal changes of somatic nuclear and mitochondrial DNA mutations in naturally progressing CLL.
Tracking co-evolution of somatic nuclear and mitochondrial DNA mutations in CLL and AML using single cell DNA and protein sequencing (Tapestri).
Longitudinal changes of somatic nuclear and mitochondrial DNA mutations in evolving CLL.
Applicability of expressed mitochondrial DNA (mtDNA) mutations to distinguish unrelated individuals.
Longitudinal changes of somatic nuclear and mitochondrial DNA mutations in evolving CLL.
Co-segregation of mitochondrial and somatic nuclear DNA mutations in AML bone marrow.
Deconvolution of chimeric populations using mitochondrial DNA mutations and germline single nucleotide polymorphisms.